The Dendrimers as Drug Delivery Platforms of the Mechanisms, Benefits, and Use in Anti-Pain: Systematice Literature Review

Drug Delivery Platforms
Najla Yusiana Wahyudi 1 Indonesia , Sri Rahayu Indonesia
1 a:1:{s:5:"en_US";s:34:"Singaperbangsa Karawang University";}
Link Copied!
Published 2024-06-30
Vol. 6 No. 1 (2024) PAGES 259-265
DOI 10.36566/ijhsrd/Vol6.Iss1/217
Views / Downloads 474 555

Background: Efforts to reduce the side effects of long-term NSAID use have prompted exploration of transdermal drug delivery, which offers advantages such as avoiding first-pass metabolism, reducing pain, allowing sustained drug release, and improving patient compliance. Dendrimers, specifically polyamidoamine (PAMAM), are attracting attention for their potential in drug delivery. PAMAM has a three-dimensional structure of monodisperses with high amino group density and internal voids suitable for drug encapsulation.

Methods: This research method uses the literature review method which begins with the collection of journals to be reviewed. The article search was conducted on the Pubmed database. Researchers searched with the keyword dendrimer. The two main synthesis methods are convergent and divergent dendrimers.

Results: : Drug molecules can be trapped in dendrimers through hydrogen, hydrophobic, or electrostatic bonds. The advantages of dendrimers include improved solubility, permeability, and targeted drug delivery, while the disadvantages are high cost, toxicity and aggregation. This system has been used in several pain medications.

Conclusions: Dendrimers are macrostructures with unique characteristics such as nanoscopic size, multifunctional surface, and high branching, making them ideal as drug delivery systems. Ketoprofen with PAMAM-type dendrimers showed that PAMAM dendrimers could significantly increase the accumulative amount of permeation of both drugs after 24 hours, compared with the drug suspension without PAMAM dendrimers. Dendrimers are multi-branched monodisperse macrostructures, derived from Greek.

The Dendrimers as Drug Delivery Platforms of the Mechanisms, Benefits, and Use in Anti-Pain: Systematice Literature Review: Drug Delivery Platforms. (2024). INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD), 6(1), 259-265. https://doi.org/10.36566/ijhsrd/Vol6.Iss1/217
Download data is not yet available.
  1. Wardoyo, A. V., Oktarlina, R. Z. The Level of Public Knowledge of Analgesic Drugs in Self-Medication to Overcome Acute Pain. Scientific Journal of Health Sandi Husada .2019; (2):156-160.
  2. Ananda, MB. Mesoporous Silica Nanoparticles Sebagai Drug Carrier pada Aplikasi Controlled Drug Delivery System. Jurnal Perancangan, Manufaktur, Material, dan Energi (Jurnal Permadi). 2020;2(3).
  3. Winarti, L. Sistem penghantaran obat tertarget, macam, jenis-jenis sistem penghantaran, dan aplikasinya. STOMATOGNATIC Jurnal Kedokteran Gigi. 2015;10(2):75-81.
  4. Yiyun, C., Na, M., Tongwen, X., Rongqiang, F., Xueyuan, W., Xiaomin, W., & Longping, W. Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Mediated By Polyamidoamine (PAMAM) Dendrimers. Journal of pharmaceutical sciences. 2007;96(3):595-602.
  5. Wang, J., Li, B., Qiu, L., Qiao, X., & Yang, H. Dendrimer-based drug delivery systems: history, challenges, and latest developments. Journal of biological engineering. 2022;16(1): 18. https://doi.org/10.1186/s13036-022-00298-5.
  6. Rahmi, D. Dendrimer Review: Definition, Synthesis, Application and Prospective. Journal of Chemistry and Packaging. 2013;35(2),:137-144.
  7. Duan, X. D., Ji, C. J., & Nie, L. Formulation And Development Of Dendrimer-Based Transdermal Patches Of Meloxicam For The Management Of Arthritis. Tropical Journal of Pharmaceutical Research. 2015:14(4), 583-590.
  8. Prajapati, R. N., Tekade, R. K., Gupta, U., Gajbhiye, V., & Jain, N. K. Dendimer-Mediated Solubilization, Formulation Development and In Vitro-in Vivo Assessment of Piroxicam. Molecular Pharmaceutics. 2009;6(3):940-950.
  9. Koç, F. E., & Şenel, M. Solubility Enhancement of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) Using Polypolypropylene Oxide Core Pamam Dendrimers. International Journal of Pharmaceutics. 2013;451(1-2):18-22.
  10. Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. Poly(amidoamine) (PAMAM) Dendritic Nanostructures For Controlled Sitespecific Delivery Of Acidic Anti-Inflammatory Active Ingredient. AAPS PharmSciTech. 2005;6(3):E536–E542. doi:10.1208/pt060367
  11. Gupta, U., Agashe, H. B., & Jain, N. K. Polypropylene Imine Dendrimer Mediated Solubility Enhancement: Effect Of Ph And Functional Groups Of Hydrophobes. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2007;10(3):358-367.
  12. Prajapati, R. N. Polyamidoamine Dendrimer-mediated Formulation Development and In Vitro-In Vivo Evaluation of Ketorolac. Asian Journal of Pharmaceutics (AJP). 2018;12(02).
  13. Prasetyo, M., Tasnim, T., Riski,S. Control of Dead Stock and Slow-Moving Drugs in the Pharmacy Installation of the Kendari City Regional General Hospital. Indonesian Journal of Health Sciences Research and Development.2023, 5(2), 63-72. DOI: https://doi.org/10.36566/ijhsrd/Vol5.Iss2/173.

Copyright (c) 2024 INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD)

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright Rights & Permissions Guide

Reproducing Published Material from other Publishers

It is absolutely essential that authors obtain permission to reproduce any published material (figures, schemes, tables or any extract of a text) which does not fall into the public domain, or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

Permission is required for:

  1. Your own works published by other Publishers and for which you did not retain copyright.
  2. Substantial extracts from anyones’ works or a series of works.
  3. Use of Tables, Graphs, Charts, Schemes and Artworks if they are unaltered or slightly modified.
  4. Photographs for which you do not hold copyright.

Permission is not required for:

  1. Reconstruction of your own table with data already published elsewhere. Please notice that in this case you must cite the source of the data in the form of either “Data from…” or “Adapted from…”.
  2. Reasonably short quotes are considered fair use and therefore do not require permission.
  3. Graphs, Charts, Schemes and Artworks that are completely redrawn by the authors and significantly changed beyond recognition do not require permission.

Obtaining Permission

In order to avoid unnecessary delays in the publication process, you should start obtaining permissions as early as possible. If in any doubt about the copyright, apply for permission. JNH cannot publish material from other publications without permission.

The copyright holder may give you instructions on the form of acknowledgement to be followed; otherwise follow the style: “Reproduced with permission from [author], [book/journal title]; published by [publisher], [year].’ at the end of the caption of the Table, Figure or Scheme.

Every mansucript should be accompanied by "Copyright Transfer Agreement" prior to the article publication

Dimension Badge

Downloads

Downloads
Crossmark Badge
Crossmark Badge
Section
Articles
Keywords
Dendrimers Mechanism Drug Anti-Pain

Similar Articles

21-30 of 38

You may also start an advanced similarity search for this article.